Behavioural economics in managed care: moving members from awareness to action

Managed care and wellness programmes rarely fail because the clinical thinking is wrong. The risk stratification is sound, the chronic pathways are evidence-based, the screening is appropriate. They fail because members do not do the thing the programme needs them to do. They know they should enrol, attend, complete, adhere — and they do not. The programme is clinically strong and behaviourally weak, and the gap between the two is where the value leaks away.

This is not a motivation problem to be solved with more communication. It is a design problem, and behavioural economics gives us a reasonably well-understood set of tools to address it. The question is not whether members are informed. It is whether the programme is designed for how people actually decide and act, rather than how we assume they should.

The awareness–action gap

Traditional programmes implicitly assume a rational sequence: inform the member, they understand, they weigh the benefit, they act. Real behaviour rarely follows that line. People discount future benefits heavily against present effort. They default to inaction when a choice is complex. They respond to friction — a form, a phone call, an unclear next step — by doing nothing, even when the payoff is real and they know it.

The result is a familiar pattern. A chronic disease management programme with strong clinical design and low enrolment. A wellness benefit with high awareness and low completion. A screening initiative that reaches people who were going to screen anyway and misses the ones it was built for. In each case the awareness is present and the action is missing, and the programme's value depends entirely on the action.

Designing for how people actually decide

Behavioural economics does not replace clinical design. It sits alongside it, shaping the moments where a member has to choose or act. A few principles do most of the work.

Defaults are powerful. Whether a member is enrolled by default or has to opt in changes participation more than almost any message. Where it is clinically and ethically appropriate, designing the default toward the healthier path removes the single largest source of drop-off — the decision to start.

Friction is a design variable. Every step between intention and action loses people. Reducing the number of steps, pre-filling what can be pre-filled, and making the next action obvious does more than exhortation ever will. Conversely, useful friction can be placed deliberately in front of choices you want members to slow down on.

Present bias is real, so bring the reward forward. Benefits that pay off in the distant future compete poorly against effort today. Incentives that are immediate, visible and concrete move behaviour more reliably than larger rewards deferred to year-end. The structure of the incentive matters as much as its size.

Salience beats volume. A single well-timed prompt at the moment of decision outperforms a stream of general communication. The question is not how often you reach the member but whether you reach them when the nudge can actually change what they do next.

Connecting behaviour to benefit

The strongest managed care designs close the loop between behaviour and benefit. A wellness activity that links to a tangible benefit outcome gives the member a reason to act that is concrete rather than abstract. A chronic programme that ties adherence to a visible advantage aligns the member's incentive with the clinical goal.

This is where design discipline matters most, because benefit-linked incentives only work if completion can be validated. An incentive tied to a behaviour the funder cannot verify is an invitation to game the system, and it erodes both the economics and the credibility of the programme. Completion validation is not administrative overhead. It is what makes a behavioural incentive real rather than notional.

Measuring what actually changed

The final discipline is measurement, and it is the one most often skipped. It is not enough to measure participation. Participation tells you people showed up. It does not tell you their behaviour changed, or that the change produced a health or cost outcome worth the spend.

Serious behavioural design measures the chain: did the member act, did the action complete, did the completion change behaviour, did the behaviour change the outcome. Each link can break, and knowing which one broke is what lets a programme improve rather than merely continue. A wellness programme that reports enrolment but cannot demonstrate outcome is reporting activity, not value.

This has to be done honestly. Not every intervention works, and behavioural design that only ever reports success is not being measured properly. The point of measurement is to find the links that are breaking and redesign them, which requires being willing to see them break.

What this means for programme design

For a funder, the implication is that managed care and wellness should be evaluated on their behavioural design as rigorously as on their clinical design. A programme that is clinically excellent and behaviourally naive will underdeliver, and the shortfall will show up as low participation, weak completion and outcomes that never quite justify the investment.

Moving members from awareness to action is not a communications task bolted onto a clinical programme. It is a design capability — defaults, friction, incentive structure, validation and honest measurement — applied from the start. The programmes that master it convert good clinical intent into measured outcomes. The ones that do not keep informing members who continue not to act.